tirzepatide 10 mg/0.5 ml Mounjaro Injection Pen mg – AlFouad Pharmacies Mounjaro (Tirzepatide) Injection 5 mg/0.5

The mean body mass index was 39.1 for one trial and 38.7 for the other

Vadher K, Patel H, Mody R et al (2022) Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: an adjusted indirect treatment comparison

Common appearances of a Mounjaro rash include: Small red patches around the injection site Raised itchy hives or welts Clusters of small itchy bumps Areas of redness with mild swelling A more widespread rash affecting multiple areas Mild reactions: Light redness, slight itching, tenderness, or small red patches around the injection area

Clinical Trial Results The SURMOUNT trials proved tirzepatide delivers unprecedented weight loss

The peptide safety and risks guide covers broader safety considerations beyond dosing accuracy